These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 9004051

  • 1. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors.
    Sheline Y, Bardgett ME, Csernansky JG.
    J Clin Psychopharmacol; 1997 Feb; 17(1):11-4. PubMed ID: 9004051
    [Abstract] [Full Text] [Related]

  • 2. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
    De Bellis MD, Geracioti TD, Altemus M, Kling MA.
    Biol Psychiatry; 1997 Feb; 33(8-9):636-41. PubMed ID: 7687151
    [Abstract] [Full Text] [Related]

  • 3. The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients.
    Lundmark J, Wålinder J, Alling C, Manniche PM, Dalgaard L.
    Eur Neuropsychopharmacol; 1994 Mar; 4(1):1-6. PubMed ID: 7515737
    [Abstract] [Full Text] [Related]

  • 4. Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.
    Mårtensson B, Nyberg S, Toresson G, Brodin E, Bertilsson L.
    Acta Psychiatr Scand; 1989 Jun; 79(6):586-96. PubMed ID: 2475012
    [Abstract] [Full Text] [Related]

  • 5. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
    Potter WZ, Scheinin M, Golden RN, Rudorfer MV, Cowdry RW, Calil HM, Ross RJ, Linnoila M.
    Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
    [Abstract] [Full Text] [Related]

  • 6. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
    Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathé AA.
    J Clin Psychopharmacol; 2010 Oct; 30(5):496-503. PubMed ID: 20814316
    [Abstract] [Full Text] [Related]

  • 7. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
    Ogawa S, Tsuchimine S, Kunugi H.
    J Psychiatr Res; 2018 Oct; 105():137-146. PubMed ID: 30219563
    [Abstract] [Full Text] [Related]

  • 8. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Hjärpe J, Söderman E, Andreou D, Sedvall GC, Agartz I, Jönsson EG.
    Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
    [Abstract] [Full Text] [Related]

  • 9. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
    Sher L, Oquendo MA, Li S, Huang YY, Grunebaum MF, Burke AK, Malone KM, Mann JJ.
    Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
    [Abstract] [Full Text] [Related]

  • 10. Day/night variation of 5-hydroxyindole acetic acid concentration in rat cerebrospinal fluid after acute and long-term administration of a selective serotonin reuptake inhibitor, fluvoxamine.
    Egashira T, Takayama F, Yamanaka Y, Takada K, Takeda H, Matsumiya T.
    Jpn J Pharmacol; 2000 Aug; 83(4):344-7. PubMed ID: 11001181
    [Abstract] [Full Text] [Related]

  • 11. A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients.
    Timmerman L, de Beurs P, Tan BK, Leijnse-Ybema H, Sanchez C, Høpfner Petersen HE, Cohen Stuart MH.
    Int Clin Psychopharmacol; 1987 Jul; 2(3):239-53. PubMed ID: 2447151
    [Abstract] [Full Text] [Related]

  • 12. Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline.
    Mendlewicz J, Pinder RM, Stulemeijer SM, Van Dorth R.
    J Affect Disord; 1982 Sep; 4(3):219-26. PubMed ID: 6182175
    [Abstract] [Full Text] [Related]

  • 13. Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder.
    Yoon HS, Hattori K, Ogawa S, Sasayama D, Ota M, Teraishi T, Kunugi H.
    J Clin Psychiatry; 2017 Sep; 78(8):e947-e956. PubMed ID: 28749090
    [Abstract] [Full Text] [Related]

  • 14. Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid.
    Bowden CL, Koslow SH, Hanin I, Maas JW, Davis JM, Robins E.
    Clin Pharmacol Ther; 1985 Mar; 37(3):316-24. PubMed ID: 2578912
    [Abstract] [Full Text] [Related]

  • 15. Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man.
    Ashby P, Verrier M, Warsh JJ, Price KS.
    J Neurol Neurosurg Psychiatry; 1976 Dec; 39(12):1191-200. PubMed ID: 1011029
    [Abstract] [Full Text] [Related]

  • 16. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
    Varela M, Alexiou GA, Liakopoulou M, Papakonstantinou E, Pitsouni D, Alevizopoulos GA.
    J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
    [Abstract] [Full Text] [Related]

  • 17. [Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
    Raucoules D, Levy C, Azorin JM, Bruno M, Valli M.
    Encephale; 1992 Apr; 18(6):611-6. PubMed ID: 1285270
    [Abstract] [Full Text] [Related]

  • 18. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.
    Sher L, Carballo JJ, Grunebaum MF, Burke AK, Zalsman G, Huang YY, Mann JJ, Oquendo MA.
    Bipolar Disord; 2006 Oct; 8(5 Pt 2):543-50. PubMed ID: 17042827
    [Abstract] [Full Text] [Related]

  • 19. Effect of propranolol on monoamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia.
    Scheinin M, van Kammen DP, Ninan PT, Linnoila M.
    Clin Pharmacol Ther; 1984 Jul; 36(1):33-9. PubMed ID: 6203678
    [Abstract] [Full Text] [Related]

  • 20. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
    Molchan SE, Lawlor BA, Hill JL, Martinez RA, Davis CL, Mellow AM, Rubinow DR, Sunderland T.
    Biol Psychiatry; 1991 Jun 01; 29(11):1110-8. PubMed ID: 1714776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.